Osaka, Japan

Manabu Katou

This inventor holds 19 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Daikin Industries, Ltd., Shionogi Company Limited, The University of Tokyo. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manabu Katou. Retrieved from https://idiyas.com/inventor/manabu-katou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 78.9

 

 

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 183(Granted Patents)


Location History:

  • Kusatsu, JP (2008 - 2013)
  • Osaka, JP (2013 - 2019)
  • Toyonaka, JP (2014 - 2019)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: The Innovative Journey of Manabu Katou

Introduction

Manabu Katou, based in Osaka, Japan, is a renowned inventor with a notable portfolio of 19 patents. His work primarily focuses on innovative compounds with significant pharmaceutical applications. With a strong background in the industry, Katou has made remarkable contributions to the field of medicinal chemistry.

Latest Patents

Among his latest patents is a dihydropyrazolopyrazinone derivative known for its MGAT2 inhibitory activity. This compound, represented by a specific formula, demonstrates potential in addressing metabolic disorders. Another significant innovation involves a compound aimed at providing novel ACC2 selective inhibitory activity. The pharmaceutical composition derived from this compound may have far-reaching implications in therapeutic applications.

Career Highlights

Throughout his career, Manabu Katou has been affiliated with prominent companies such as Daikin Industries, Ltd. and Shionogi & Company Limited. His expertise in the realm of medicinal chemistry has allowed him to contribute effectively to the development of groundbreaking drug candidates.

Collaborations

Katou has collaborated with several notable professionals, including Kaichi Tsuji and Masahiko Chouji. These partnerships have fostered a creative environment conducive to innovation, leading to the successful development of various patented compounds.

Conclusion

Manabu Katou's enduring passion for innovation and his extensive patent portfolio underscore his impact on the pharmaceutical industry. As he continues to explore new avenues in medicinal chemistry, his contributions are expected to advance therapeutic strategies and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…